Gritstone bio, Inc. Common Stock
GRTS
GRTS was delisted on the 21st of October, 2024.
56 hedge funds and large institutions have $262M invested in Gritstone bio, Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 22 increasing their positions, 13 reducing their positions, and 9 closing their positions.
69% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 13
11% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 9
6% more capital invested
Capital invested by funds: $247M → $262M (+$15.2M)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
8% less funds holding
Funds holding: 61 → 56 (-5)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$3.43M |
| 2 |
CC
Casdin Capital
New York
|
+$3.25M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$1.67M |
| 4 |
CAPTRUST Financial Advisors
Raleigh,
North Carolina
|
+$337K |
| 5 |
State Street
Boston,
Massachusetts
|
+$241K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AG
Artal Group
Luxembourg
|
-$2.16M |
| 2 |
Marshall Wace
London,
United Kingdom
|
-$1.29M |
| 3 |
Schroder Investment Management Group
London,
United Kingdom
|
-$462K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$339K |
| 5 |
VEA
Virtus ETF Advisers
New York
|
-$222K |
GRTS Hedge Fund Activity: Q4 2019 in Review
56 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in Gritstone bio, Inc. Common Stock (GRTS) for Q4 2019, worth a combined $262M — up 6.2% from $247M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new GRTS positions and 9 closed out — a net gain of 1 holder — while 22 added to existing stakes and 13 trimmed.
The largest buyer was BlackRock, adding an estimated $3.43M. The largest seller was Artal Group, exiting entirely with an estimated $2.16M sold.
- 56 institutional investors held Gritstone bio, Inc. Common Stock (GRTS) as of Q4 2019, down from 61 in Q3 2019.
- Funds reported $262M of Gritstone bio, Inc. Common Stock stock for Q4 2019, up 6.2% quarter-over-quarter.
- 10 funds opened new Gritstone bio, Inc. Common Stock positions in Q4 2019 and 9 closed out, a net change of +1 holder.
- The largest Gritstone bio, Inc. Common Stock buyer in Q4 2019 was BlackRock, an estimated $3.43M added.
- The largest Gritstone bio, Inc. Common Stock seller in Q4 2019 was Artal Group, an estimated $2.16M sold.
Based on aggregated 13F filings for Q4 2019.